featured allergy aticle

FDA Advisors Back Full Approval of Paxlovid

FRIDAY, March 17, 2023 (HealthDay News) -- Paxlovid, a medication that has helped millions of high-risk COVID patients avoid hospitalization and death since late 2021, moved one step closer to getting full approval from the U.S. Food and Drug Administration on Thursday.

An FDA advisory panel voted 16-1 that the Pfizer drug remains a safe and effective treatment and should be given full approval. It has only received emergency use authorization until now, but the FDA is expected to make a final decision on full approval by May, the Associated Press reported.

Full Article

Check Asthma levels in Another City

Best & worst cities for asthma sufferers

Compare asthma levels in another city